Advertisement
Screener

AngioDynamics, Inc. (ANGO) Right-of-Use Asset Obtained in Exchange for Operating Lease Liability

1.7 / 5 stars · 26/77 Roast Me

AngioDynamics, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability

AngioDynamics, Inc. (ANGO) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $2.75 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.

Financial Statements › Notes › Leases

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-07-14

  • AngioDynamics, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-05-31 was -$756.00K.
  • AngioDynamics, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-02-28 was $33.00K.
  • AngioDynamics, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-11-30 was $3.48M.
  • AngioDynamics, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-08-31 was $0.00.
  • AngioDynamics, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2026 was $2.75M.
  • AngioDynamics, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • AngioDynamics, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $3.06M, a 263.93% increase from fiscal 2023.
  • AngioDynamics, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $840.00K, a 2233.33% increase from fiscal 2022.
Period endRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month
2026-05-31-$756.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14
-$723.00K
derived: sum of 2 quarters · filed 2026-07-14
$2.75M
derived: sum of 3 quarters · filed 2026-07-14
$2.75M
10-K · filed 2026-07-14
2026-02-28$33.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-02
$3.51M
derived: sum of 2 quarters · filed 2026-04-02
$3.51M
10-Q · filed 2026-04-02
$3.51M
derived: sum of 4 quarters · filed 2026-07-14
2025-11-30$3.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-06
$3.48M
10-Q · filed 2026-01-06
$3.48M
derived: sum of 3 quarters · filed 2026-07-14
$3.48M
derived: sum of 4 quarters · filed 2026-07-14
2025-08-31$0.00
10-Q · filed 2025-10-02
$0.00
derived: sum of 2 quarters · filed 2026-07-14
$0.00
derived: sum of 3 quarters · filed 2026-07-14
$0.00
derived: sum of 4 quarters · filed 2026-07-14
2025-05-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14
$0.00
derived: sum of 2 quarters · filed 2026-07-14
$0.00
derived: sum of 3 quarters · filed 2026-07-14
$0.00
10-K · filed 2026-07-14
2025-02-28$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-02
$0.00
derived: sum of 2 quarters · filed 2026-04-02
$0.00
10-Q · filed 2026-04-02
$2.44M
derived: sum of 4 quarters · filed 2026-04-02
2024-11-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-06
$0.00
10-Q · filed 2026-01-06
$2.44M
derived: sum of 3 quarters · filed 2026-01-06
$2.68M
derived: sum of 4 quarters · filed 2026-01-06
2024-08-31$0.00
10-Q · filed 2025-10-02
$2.44M
derived: sum of 2 quarters · filed 2025-10-02
$2.68M
derived: sum of 3 quarters · filed 2025-10-02
$2.68M
derived: sum of 4 quarters · filed 2025-10-02
2024-05-31$2.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-18
$2.68M
derived: sum of 2 quarters · filed 2025-07-18
$2.68M
derived: sum of 3 quarters · filed 2025-07-18
$3.06M
10-K · filed 2025-07-18
2024-02-29$237.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-02
$237.00K
derived: sum of 2 quarters · filed 2025-04-02
$618.00K
10-Q · filed 2025-04-02
$1.46M
derived: sum of 4 quarters · filed 2025-04-02
2023-11-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-08
$381.00K
10-Q · filed 2025-01-08
$1.22M
derived: sum of 3 quarters · filed 2025-01-08
$1.22M
derived: sum of 4 quarters · filed 2025-01-08
2023-08-31$381.00K
10-Q · filed 2024-10-03
$1.22M
derived: sum of 2 quarters · filed 2024-10-03
$1.22M
derived: sum of 3 quarters · filed 2024-10-03
$1.22M
derived: sum of 4 quarters · filed 2024-10-03
2023-05-31$840.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-25
$840.00K
derived: sum of 2 quarters · filed 2024-07-25
$840.00K
derived: sum of 3 quarters · filed 2024-07-25
$840.00K
10-K · filed 2024-07-25
2023-02-28$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09
$0.00
derived: sum of 2 quarters · filed 2024-04-09
$0.00
10-Q · filed 2024-04-09
$3.00K
derived: sum of 4 quarters · filed 2024-04-09
2022-11-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-08
$0.00
10-Q · filed 2024-01-08
$3.00K
derived: sum of 3 quarters · filed 2024-01-08
$36.00K
derived: sum of 4 quarters · filed 2024-01-08
2022-08-31$0.00
10-Q · filed 2023-10-05
$3.00K
derived: sum of 2 quarters · filed 2023-10-05
$36.00K
derived: sum of 3 quarters · filed 2023-10-05
$36.00K
derived: sum of 4 quarters · filed 2023-10-05
2022-05-31$3.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-03
$36.00K
derived: sum of 2 quarters · filed 2023-08-03
$36.00K
derived: sum of 3 quarters · filed 2023-08-03
$36.00K
10-K · filed 2023-08-03
2022-02-28$33.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-31
$33.00K
derived: sum of 2 quarters · filed 2023-03-31
$33.00K
10-Q · filed 2023-03-31
$33.00K
derived: sum of 4 quarters · filed 2023-03-31
2021-11-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-06
$0.00
10-Q · filed 2023-01-06
$0.00
derived: sum of 3 quarters · filed 2023-01-06
$1.10M
derived: sum of 4 quarters · filed 2023-01-06
2021-08-31$0.00
10-Q · filed 2022-10-11
$0.00
derived: sum of 2 quarters · filed 2022-10-11
$1.10M
derived: sum of 3 quarters · filed 2022-10-11
$1.10M
derived: sum of 4 quarters · filed 2022-10-11
2021-05-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22
$1.10M
derived: sum of 2 quarters · filed 2022-07-22
$1.10M
derived: sum of 3 quarters · filed 2022-07-22
$1.58M
10-K · filed 2022-07-22
2021-02-28$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-07
$1.10M
derived: sum of 2 quarters · filed 2022-04-07
$1.58M
10-Q · filed 2022-04-07
$2.91M
derived: sum of 4 quarters · filed 2022-04-07
2020-11-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-07
$487.00K
10-Q · filed 2022-01-07
$1.81M
derived: sum of 3 quarters · filed 2022-01-07
$7.41M
derived: sum of 4 quarters · filed 2022-01-07
2020-08-31$487.00K
10-Q · filed 2021-09-30
$1.81M
derived: sum of 2 quarters · filed 2021-09-30
$7.41M
derived: sum of 3 quarters · filed 2021-09-30
$7.41M
derived: sum of 4 quarters · filed 2021-09-30
2020-05-31$1.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-27
$6.92M
derived: sum of 2 quarters · filed 2021-07-27
$6.92M
derived: sum of 3 quarters · filed 2021-07-27
$6.92M
10-K · filed 2021-07-27
2020-02-29$5.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31
$5.59M
derived: sum of 2 quarters · filed 2021-03-31
$5.59M
10-Q · filed 2021-03-31
2019-11-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-08
$0.00
10-Q · filed 2021-01-08
2019-08-31$0.00
10-Q · filed 2020-10-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
SI-BONE, Inc. (SIBN)United States$0.830B-49.82